Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Cardiology

Interventions & Surgery: Fixing the Valve

At a Glance

When mitral valve stenosis becomes severe and causes symptoms, treatment may involve a catheter-based balloon procedure or surgery to repair or replace the valve. The choice depends on valve flexibility, calcium, clot, leakage, and overall health, with guidance from a multidisciplinary Heart Team.

When mitral stenosis becomes severe and begins to cause symptoms or put a strain on your heart, medications alone are no longer sufficient. Some patients are monitored indefinitely, but when severe symptomatic disease occurs, you and your medical team will evaluate an intervention that physically opens the “door” or replaces it entirely [1][2].

The First-Line Option: Balloon Procedure (PMBC)

For clinically significant rheumatic mitral stenosis with favorable anatomy, PMBC is often the first choice. (Note that PMBC is generally not a treatment for degenerative MAC). This is not “open-heart” surgery. Instead, a doctor threads a thin tube (catheter) through a vein in your leg up to your heart. A specialized balloon is then inflated inside the narrowed valve to stretch it open and break apart the fused edges (commissures) [3][4].

  • Who is a candidate? This procedure works best when the valve is still somewhat flexible and not heavily covered in calcium. Doctors use the Wilkins score to decide; a score of 8 or less is generally considered more favorable. However, a left atrial clot, heavy calcification, or significant mitral regurgitation are contraindications [4][5].
  • Success and Complications: The success rate is high—often between 90% and 97% in experienced hands—but varies by center [6][7]. However, because the procedure involves stretching the valve, there is a small risk of creating too much “leakiness” (mitral regurgitation), which might require emergency surgery to fix [6][8].
  • The Long-Term Reality: While PMBC provides immediate relief, it is not always a permanent fix. About 24% to 26% of patients experience restenosis (the valve narrowing again) within 6 to 9 years [9][10]. If this happens, the procedure can sometimes be repeated, or you may move on to surgery [11].

Surgical Options: Repair vs. Replacement

If your valve is too damaged, calcified, or stiff for a balloon procedure—or if you have significant Mitral Annular Calcification (MAC)—surgery is the standard path. Significant MAC surgery can be technically high risk [1][4].

  • Mitral Valve Repair: In some rheumatic cases, a surgeon can manually repair the valve. While successful repair is preferred for your heart long-term, it is technically difficult in rheumatic disease and many require replacement. Repair also carries a higher risk of needing a second operation later compared to a replacement [12][13].
  • Mitral Valve Replacement: This involves removing your damaged valve and sewing in a new one. There are two main types:
    1. Mechanical Valves: Made of durable materials like carbon and metal. They can last a lifetime but require you to take Warfarin (a blood thinner) for the rest of your life to prevent clots. You will need regular blood tests to keep your INR in a specific range (usually 2.5 to 3.5) [14][15].
    2. Bioprosthetic Valves: Made from animal tissue (cow or pig). These do not always require lifelong blood thinners based solely on the valve, but anticoagulation is often used early after surgery, and may be lifelong if you have atrial fibrillation. Tissue valve durability varies substantially with age—often lasting 10 to 15 years—meaning you may eventually need another surgery or a valve-in-valve procedure [16][17].

Choosing Your Care Team

Mitral stenosis is a complex, mechanical disease. Current medical guidelines strongly recommend that decisions be made by a multidisciplinary Heart Team—a group that includes cardiologists, imaging specialists, and heart surgeons working together [18][19].

When evaluating where to have your procedure, look for a Heart Valve Center of Excellence. These centers typically have:

  • High volumes of mitral procedures, which is linked to better outcomes and lower complication rates [20][21].
  • Advanced imaging tools like 3D Transesophageal Echo (TEE) to precisely map the valve before the procedure [22][23].
  • “Emergency rescue” capabilities, meaning they have surgeons ready on-site in the rare event that a balloon procedure causes a complication [8][18].

After either procedure, your hospital stay and recovery will vary. PMBC often requires only a short stay, while surgery involves several days in the hospital, sternal healing, and cardiac rehabilitation. Your Heart Team will guide your follow-up tests and medications.

Common questions in this guide

What is the balloon procedure for mitral valve stenosis?
Percutaneous mitral balloon commissurotomy (PMBC) uses a catheter passed from a vein in the leg to place and inflate a balloon inside the narrowed valve. It stretches the valve and separates fused edges without open-heart surgery. It is most often considered for significant rheumatic mitral stenosis when the valve is flexible and not heavily calcified.
What makes someone a good candidate for PMBC?
Doctors use the Wilkins score to assess valve structure; a score of 8 or lower is generally more favorable. A clot in the left atrium, heavy calcium, or significant mitral regurgitation, meaning leakage through the valve, can make PMBC unsafe or unsuitable. Your Heart Team combines these findings with your symptoms and overall health.
How successful is PMBC, and can the valve narrow again?
At experienced centers, PMBC opens the valve successfully in about 90% to 97% of cases, although results vary. Mitral stenosis can return over time, and about 24% to 26% of patients develop restenosis within 6 to 9 years. A repeat balloon procedure or surgery may then be considered.
When is mitral valve surgery needed instead of a balloon procedure?
Surgery is usually considered when the valve is too damaged, stiff, or calcified for PMBC, or when significant mitral annular calcification is present. A surgeon may repair some rheumatic valves, but repair can be difficult and replacement is often needed. The best choice depends on the valve's structure and the Heart Team's assessment.
What are the differences between mechanical and tissue mitral valves?
Mechanical valves are very durable, often lasting a lifetime, but they require lifelong warfarin and regular INR blood tests to help prevent clots. Bioprosthetic valves made from animal tissue often do not require lifelong anticoagulation solely because of the valve, although blood thinners may be used early after surgery or long term for another reason such as atrial fibrillation. They typically last about 10 to 15 years, so another procedure may eventually be needed.
How should I choose a hospital or Heart Team for mitral stenosis treatment?
Look for a multidisciplinary Heart Team that includes cardiologists, imaging specialists, and heart surgeons. A high-volume valve center with advanced imaging, such as 3D transesophageal echocardiography, and surgeons available for emergency rescue can help manage complex cases and rare complications. Ask about the center's procedure volume and outcomes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my valve anatomy favorable for a balloon procedure (PMBC), and specifically, what is my Wilkins score?
  2. 2.If we choose the balloon procedure, what is this hospital’s success rate and how often do patients here require 'emergency rescue' surgery?
  3. 3.If I need surgery, am I a candidate for a valve repair, or is a replacement more likely given the amount of calcium on my valve?
  4. 4.For a valve replacement, what are the pros and cons of a mechanical valve versus a bioprosthetic valve for someone of my age and lifestyle?
  5. 5.Does your center use a multidisciplinary 'Heart Team' to review complex cases like mine?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.

    Wunderlich NC, Dalvi B, Ho SY, et al.

    Current cardiology reports 2019; (21(3)):14 doi:10.1007/s11886-019-1099-7.

    PMID: 30815750
  2. 2

    Intracardiac Echocardiography-Guided Percutaneous Mitral Balloon Commissurotomy: Technique and Early Experience.

    Hassanin A, Alom M, Potluri S, Al-Azizi K

    Structural heart : the journal of the Heart Team 2024; (8(5)):100330 doi:10.1016/j.shj.2024.100330.

    PMID: 39290675
  3. 3

    Advances in Rheumatic Mitral Stenosis: Echocardiographic, Pathophysiologic, and Hemodynamic Considerations.

    Silbiger JJ

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2021; (34(7)):709-722.e1 doi:10.1016/j.echo.2021.02.015.

    PMID: 33652082
  4. 4

    Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty.

    Mohamed Ali A, Packer EJS, Omdal TR, et al.

    Current problems in cardiology 2023; (48(12)):102021 doi:10.1016/j.cpcardiol.2023.102021.

    PMID: 37544629
  5. 5

    Novel Prognostic Score for Immediate and Late Success After Percutaneous Mitral Balloon Commissurotomy in Patients With Mitral Stenosis.

    Prota-Filho LEB, Meneguz-Moreno RA, Queiroz CCV, et al.

    The Journal of invasive cardiology 2020; (32(6)):211-217.

    PMID: 32269178
  6. 6

    Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: A systematic review and meta-analysis.

    Abu Rmilah AA, Tahboub MA, Alkurashi AK, et al.

    International journal of cardiology. Heart & vasculature 2021; (33()):100765 doi:10.1016/j.ijcha.2021.100765.

    PMID: 33889711
  7. 7

    Balloon Mitral Valvotomy With the Accura Double-Lumen Balloon Catheter: Immediate and One-Year Clinical Outcomes.

    Khanal S, Yamasandi Siddegowda S, Kumar B

    Cureus 2022; (14(4)):e24610 doi:10.7759/cureus.24610.

    PMID: 35651439
  8. 8

    Surgical rescue mitral valve procedure post percutaneous transluminal mitral commissurotomy-a single-center observational study.

    Rajan VKA, Chandran S, Kaskar A, et al.

    Indian journal of thoracic and cardiovascular surgery 2024; (40(3)):327-331 doi:10.1007/s12055-023-01654-w.

    PMID: 38681723
  9. 9

    Independent Clinical and Echocardiographic Predictors of Restenosis After Percutaneous Mitral Balloon Commissurotomy in a Large, Consecutive Cohort Followed for 24 Years.

    Meneguz-Moreno RA, Ferreira-Neto AN, Gomes NL, et al.

    The Journal of invasive cardiology 2023; (35(3)):E113-E121 doi:10.25270/jic/22.00328.

    PMID: 36884359
  10. 10

    Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis.

    Dadjo Y, Moshkani Farahani M, Nowshad R, et al.

    BMC cardiovascular disorders 2021; (21(1)):355 doi:10.1186/s12872-021-02175-3.

    PMID: 34320949
  11. 11

    Redo Scoring for Prediction of Success of Redo-Percutaneous Balloon Mitral Valvuloplasty in Patients with Mitral Restenosis.

    Mahfouz RA, Elawady W, Goda M, Moustafa T

    The Journal of heart valve disease 2017; (26(5)):537-546.

    PMID: 29762922
  12. 12

    Meta-Analysis of Mitral Valve Repair Versus Replacement for Rheumatic Mitral Valve Disease.

    Liao YB, Wang TKM, Wang MTM, et al.

    Heart, lung & circulation 2022; (31(5)):705-710 doi:10.1016/j.hlc.2021.11.011.

    PMID: 35120822
  13. 13

    Mitral valve repair versus replacement in patients with rheumatic heart disease.

    Chen SW, Chen CY, Chien-Chia Wu V, et al.

    The Journal of thoracic and cardiovascular surgery 2022; (164(1)):57-67.e11 doi:10.1016/j.jtcvs.2020.07.117.

    PMID: 32994098
  14. 14

    Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A Randomized Trial.

    Chu MWA, Ruel M, Graeve A, et al.

    The Annals of thoracic surgery 2023; (115(4)):929-938 doi:10.1016/j.athoracsur.2022.12.031.

    PMID: 36610532
  15. 15

    Horseshoe thrombus in a patient with mechanical prosthetic mitral valve: A case report and review of literature.

    Mehra S, Movahed A, Espinoza C, Marcu CB

    World journal of clinical cases 2015; (3(9)):838-42 doi:10.12998/wjcc.v3.i9.838.

    PMID: 26380832
  16. 16

    Survival After Mechanical vs Biological Mitral Valve Replacement: Influence of Age vs Operative Mortality Score.

    Choi JW, Gaca J, Zwischenberger BA, et al.

    The Annals of thoracic surgery 2026; (122(1)):75-82 doi:10.1016/j.athoracsur.2026.01.044.

    PMID: 41698456
  17. 17

    Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years.

    Chikwe J, Chiang YP, Egorova NN, et al.

    JAMA 2015; (313(14)):1435-42 doi:10.1001/jama.2015.3164.

    PMID: 25871669
  18. 18

    Preoperative Planning of Transapical Beating Heart Mitral Valve Repair for Safe Adaptation in Clinical Practice.

    Heuts S, Daemen JHT, Streukens SAF, et al.

    Innovations (Philadelphia, Pa.) 2018; (13(3)):200-206 doi:10.1097/IMI.0000000000000506.

    PMID: 29912141
  19. 19

    [Towards the age of computer-assisted surgery: how to establish a robotic-assisted mitral surgery program with a last-generation platform].

    Agnino A, Graniero A, Albano G, et al.

    Giornale italiano di cardiologia (2006) 2021; (22(8)):648-656 doi:10.1714/3641.36221.

    PMID: 34310568
  20. 20

    Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution.

    El-Eshmawi A, Costa AC, Boateng P, et al.

    Current opinion in cardiology 2023; (38(2)):143-148 doi:10.1097/HCO.0000000000000991.

    PMID: 36200272
  21. 21

    Contemporary outcomes in reoperative mitral valve surgery.

    Mehaffey HJ, Hawkins RB, Schubert S, et al.

    Heart (British Cardiac Society) 2018; (104(8)):652-656 doi:10.1136/heartjnl-2017-312047.

    PMID: 28982718
  22. 22

    Three-dimensional transesophageal echocardiography measurement of mitral valve area in patients with rheumatic mitral stenosis: multiplanar reconstruction or 3D direct planimetry?

    Zhong X, Chen W, Shi Z, et al.

    The international journal of cardiovascular imaging 2021; (37(1)):99-107 doi:10.1007/s10554-020-01950-1.

    PMID: 32719991
  23. 23

    Characteristics and immediate outcomes of patients who underwent percutaneous balloon mitral valvuloplasty at the Jakaya Kikwete Cardiac Institute, Tanzania.

    Mutagaywa RK, Cramer MJ, Chillo P, et al.

    Cardiovascular journal of Africa 2024; (35(1)):16-26 doi:10.5830/CVJA-2022-068.

    PMID: 36745007

This page explains treatment options for mitral valve stenosis for informational purposes only and does not constitute medical advice. Your cardiologist and Heart Team can advise you about the safest option for your anatomy and health.

Get notified when new evidence is published on mitral valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.